Cannabinoids May Improve Appetite, Behavior in Dementia

For patients with dementia, cannabinoids may be a promising intervention for treating neuropsychiatric symptoms (NPS) and the refusing of food,

Read more

Enlafax XR

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ENLAFAX-XR contains the active ingredient venlafaxine (as

Read more

APO-Paroxetine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PAROXETINE TABLETS Paroxetine hydrochloride Consumer Medicine Information

Read more